These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12380350)

  • 21. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    Rev Med Brux; 2006; 27(3):167-72. PubMed ID: 16894955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [First antibody against IgE in view. Hope for severely ill asthmatic patients ].
    Buhl R
    MMW Fortschr Med; 2005 Sep; 147(39):56. PubMed ID: 16245785
    [No Abstract]   [Full Text] [Related]  

  • 23. Omalizumab: efficacy in allergic disease.
    Spector S
    Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the IgE molecule in allergic and asthmatic diseases: review of the IgE molecule and clinical efficacy.
    Poole JA; Matangkasombut P; Rosenwasser LJ
    J Allergy Clin Immunol; 2005 Mar; 115(3):S376-85. PubMed ID: 15753882
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ray of hope for therapy of severe allergic asthma: blockade of IgE closes the treatment gap].
    MMW Fortschr Med; 2005 Oct; 147(43):52-3. PubMed ID: 16302425
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictivity of allergic sensitization (RAST) for the onset of allergic diseases in adults.
    Schoefer Y; Schäfer T; Meisinger C; Wichmann HE; Heinrich J;
    Allergy; 2008 Jan; 63(1):81-6. PubMed ID: 18053017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omalizumab in the treatment of allergic respiratory disease.
    Clark J; Chiang D; Casale TB
    J Asthma; 2006 Mar; 43(2):87-93. PubMed ID: 16517423
    [No Abstract]   [Full Text] [Related]  

  • 30. [Omalizumab. A monoclonal antibody against IgE].
    Hennemann A
    Med Monatsschr Pharm; 2004 Dec; 27(12):404-7. PubMed ID: 15646688
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-IgE therapy combined with specific immunotherapy: pro.
    Wahn U; Hamelmann E
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):269-71. PubMed ID: 15119047
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P; Hauser C; Rochat T
    Rev Med Suisse; 2007 Apr; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-IgE and other antibody targets in asthma.
    Singh J; Kraft M
    Handb Exp Pharmacol; 2008; (181):257-88. PubMed ID: 18071950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-IgE: a significant breakthrough in the treatment of airway allergic diseases.
    Louis R
    Allergy; 2004 Jul; 59(7):698-700. PubMed ID: 15180755
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
    J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technology evaluation: omalizumab, Genentech/Novartis/Tanox.
    Lazaar AL
    Curr Opin Mol Ther; 2003 Feb; 5(1):81-9. PubMed ID: 12669476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nose and lung, two of a kind?
    Fokkens W; van Drunen CM
    Allergy; 2006 Jun; 61(6):653-5. PubMed ID: 16677232
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phototherapy of nasal mucosa: is ultraviolet light modify allergic rhinitis (interview by Dr. Judith Neumaier)].
    Grevers G
    MMW Fortschr Med; 2005 Jun; 147(23):12. PubMed ID: 15981898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.